{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:33:10Z","timestamp":1794411190282,"version":"4.9.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.biomaterials.2024.122573","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T09:31:46Z","timestamp":1713346306000},"page":"122573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Polymeric micellar nanoparticles for effective CRISPR\/Cas9 genome editing in cancer"],"prefix":"10.1016","volume":"309","author":[{"given":"Yuzhen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8558-062X","authenticated-orcid":false,"given":"Chuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1871-5448","authenticated-orcid":false,"given":"Yi Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biomaterials.2024.122573_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3390\/v10060291","article-title":"Potential application of the CRISPR\/Cas9 system against herpesvirus infections","volume":"10","author":"Chen","year":"2018","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122573_bib2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.tig.2022.12.001","article-title":"Clinical progress in genome-editing technology and in vivo delivery techniques","volume":"39","author":"Khirallah","year":"2023","journal-title":"Trends Genet."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122573_bib3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41467-023-35886-6","article-title":"Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing","volume":"14","author":"Tao","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.biomaterials.2024.122573_bib4","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1101\/gr.171264.113","article-title":"Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA","volume":"24","author":"Ramakrishna","year":"2014","journal-title":"Genome Res."},{"issue":"6","key":"10.1016\/j.biomaterials.2024.122573_bib5","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1021\/acs.accounts.9b00106","article-title":"Delivery aspects of CRISPR\/Cas for in vivo genome editing","volume":"52","author":"Wilbie","year":"2019","journal-title":"Acc. Chem. Res."},{"issue":"11","key":"10.1016\/j.biomaterials.2024.122573_bib6","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122573_bib7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122573_bib8","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1038\/s41467-020-17029-3","article-title":"Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing","volume":"11","author":"Wei","year":"2020","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.biomaterials.2024.122573_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201902552","article-title":"Innovative precision gene-editing tools in personalized cancer medicine","volume":"7","author":"Dai","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2024.122573_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2019.11.005","article-title":"Rational designs of in vivo CRISPR-Cas delivery systems","volume":"168","author":"Xu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2024.122573_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.addr.2020.03.001","article-title":"Synthetic multi-layer nanoparticles for CRISPR-Cas9 genome editing","volume":"168","author":"Tang","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"15","key":"10.1016\/j.biomaterials.2024.122573_bib12","doi-asserted-by":"crossref","first-page":"9874","DOI":"10.1021\/acs.chemrev.6b00799","article-title":"CRISPR\/Cas9-based genome editing for disease modeling and therapy: challenges and opportunities for nonviral delivery","volume":"117","author":"Wang","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biomaterials.2024.122573_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119736","article-title":"Ultrasound-activated particles as CRISPR\/Cas9 delivery system for androgenic alopecia therapy","volume":"232","author":"Ryu","year":"2020","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122573_bib14","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/s41467-019-09656-2","article-title":"A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system","volume":"10","author":"LaFleur","year":"2019","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.biomaterials.2024.122573_bib15","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","article-title":"CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response","volume":"24","author":"Haapaniemi","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2024.122573_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2020.124688","article-title":"Efficient CRISPR\/Cas9 gene-chemo synergistic cancer therapy via a stimuli-responsive chitosan-based nanocomplex elicits anti-tumorigenic pathway effect","volume":"393","author":"Zhang","year":"2020","journal-title":"Chem. Eng. J."},{"issue":"17","key":"10.1016\/j.biomaterials.2024.122573_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202000208","article-title":"Aptamer\/Peptide-functionalized genome-editing system for effective immune restoration through reversal of PD-L1-mediated cancer immunosuppression","volume":"32","author":"He","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2024.122573_bib18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2019.01.017","article-title":"CRISPR-Cas9 for cancer therapy: opportunities and challenges","volume":"447","author":"Chen","year":"2019","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122573_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12943-023-01738-6","article-title":"Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy","volume":"22","author":"Liu","year":"2023","journal-title":"Mol. Cancer"},{"issue":"17","key":"10.1016\/j.biomaterials.2024.122573_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202206981","article-title":"CRISPR\/Cas9 and chlorophyll coordination micelles for cancer treatment by genome editing and photodynamic therapy","volume":"19","author":"Zhang","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2024.122573_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mattod.2018.12.003","article-title":"Material solutions for delivery of CRISPR\/Cas-based genome editing tools: current status and future outlook","volume":"26","author":"Wan","year":"2019","journal-title":"Mater. Today"},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122573_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202205318","article-title":"Folate receptor-mediated delivery of Cas9 RNP for enhanced immune checkpoint disruption in cancer cells","volume":"19","author":"Lin","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2024.122573_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.100895","article-title":"Harnessing nanoparticles for the efficient delivery of the CRISPR\/Cas9 system","volume":"34","author":"Rahimi","year":"2020","journal-title":"Nano Today"},{"issue":"15","key":"10.1016\/j.biomaterials.2024.122573_bib24","article-title":"Microfluidic and nanofluidic intracellular delivery","volume":"8","author":"Hur","year":"2021","journal-title":"Adv. Sci."},{"issue":"10","key":"10.1016\/j.biomaterials.2024.122573_bib25","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41569-022-00683-z","article-title":"RNA-targeting and gene editing therapies for transthyretin amyloidosis","volume":"19","author":"Aimo","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"issue":"8","key":"10.1016\/j.biomaterials.2024.122573_bib26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"issue":"7\u20138","key":"10.1016\/j.biomaterials.2024.122573_bib27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41417-019-0141-7","article-title":"Liposomal delivery of CRISPR\/Cas9","volume":"27","author":"Zhen","year":"2020","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.biomaterials.2024.122573_bib28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jconrel.2020.07.033","article-title":"Tropism-facilitated delivery of CRISPR\/Cas9 system with chimeric antigen receptor-extracellular vesicles against B-cell malignancies","volume":"326","author":"Xu","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biomaterials.2024.122573_bib29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2020.04.010","article-title":"Delivery of CRISPR\/Cas systems for cancer gene therapy and immunotherapy","volume":"168","author":"Song","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.biomaterials.2024.122573_bib30","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1093\/nar\/gkz137","article-title":"Antibody-targeted chromatin enables effective intracellular delivery and functionality of CRISPR\/Cas9 expression plasmids","volume":"47","author":"Killian","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.biomaterials.2024.122573_bib31","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1038\/am.2017.185","article-title":"Lipid nanoparticle-mediated efficient delivery of CRISPR\/Cas9 for tumor therapy","volume":"9","author":"Zhang","year":"2017","journal-title":"NPG Asia Mater."},{"key":"10.1016\/j.biomaterials.2024.122573_bib32","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jconrel.2019.05.019","article-title":"Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR\/Cas9 system suppressed the metastasis of pancreatic cancer","volume":"304","author":"Li","year":"2019","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122573_bib33","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1021\/acsnano.7b07874","article-title":"Macrophage-specific in vivo gene editing using cationic lipid-assisted polymeric nanoparticles","volume":"12","author":"Luo","year":"2018","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.biomaterials.2024.122573_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/marc.201800068","article-title":"Cationic polymer-mediated CRISPR\/Cas9 plasmid delivery for genome editing","volume":"40","author":"Zhang","year":"2019","journal-title":"Macromol. Rapid Commun."},{"issue":"52","key":"10.1016\/j.biomaterials.2024.122573_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202004879","article-title":"Photo-enhanced CRISPR\/Cas9 system enables robust PD-L1 gene disruption in cancer cells and cancer stem-Like cells for efficient cancer immunotherapy","volume":"16","author":"Zhao","year":"2020","journal-title":"Small"},{"issue":"21","key":"10.1016\/j.biomaterials.2024.122573_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201901187","article-title":"A rationally designed semiconducting polymer brush for NIR-II imaging-guided light-triggered remote control of CRISPR\/Cas9 genome editing","volume":"31","author":"Li","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2024.122573_bib37","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.actbio.2020.07.027","article-title":"Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery","volume":"114","author":"Noureddine","year":"2020","journal-title":"Acta Biomater."},{"issue":"4","key":"10.1016\/j.biomaterials.2024.122573_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav7199","article-title":"Near-infrared upconversion-activated CRISPR-Cas9 system: a remote-controlled gene editing platform","volume":"5","author":"Pan","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2024.122573_bib39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.addr.2020.07.004","article-title":"Progress and challenges towards CRISPR\/Cas clinical translation","volume":"154\u2013155","author":"Rosenblum","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.biomaterials.2024.122573_bib40","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1007\/s12274-020-2864-z","article-title":"Light-responsive charge-reversal nanovector for high-efficiency in vivo CRISPR\/Cas9 gene editing with controllable location and time","volume":"13","author":"Wu","year":"2020","journal-title":"Nano Res."},{"issue":"6","key":"10.1016\/j.biomaterials.2024.122573_bib41","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/anie.201708689","article-title":"Thermo-triggered release of CRISPR-Cas9 system by lipid-encapsulated gold nanoparticles for tumor therapy","volume":"57","author":"Wang","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biomaterials.2024.122573_bib42","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"41","key":"10.1016\/j.biomaterials.2024.122573_bib43","doi-asserted-by":"crossref","first-page":"38190","DOI":"10.1021\/acsami.9b15014","article-title":"Effect of PEGylated magnetic PLGA-PEI nanoparticles on primary hippocampal neurons: reduced nanoneurotoxicity and enhanced transfection efficiency with magnetofection","volume":"11","author":"Cui","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"34","key":"10.1016\/j.biomaterials.2024.122573_bib44","doi-asserted-by":"crossref","first-page":"12599","DOI":"10.1074\/jbc.RA119.009683","article-title":"Nanoscale dynamics of cholesterol in the cell membrane","volume":"294","author":"Pinkwart","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.biomaterials.2024.122573_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201900386","article-title":"CRISPR\/Cas9 delivery mediated with hydroxyl-rich nanosystems for gene editing in Aorta","volume":"6","author":"Zhang","year":"2019","journal-title":"Adv. Sci."},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122573_bib46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ygyno.2014.03.571","article-title":"A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a Gynecologic Oncology Group study","volume":"133","author":"Alvarez","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.biomaterials.2024.122573_bib47","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.biomaterials.2017.09.015","article-title":"Tumor cell-targeted delivery of CRISPR\/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma","volume":"147","author":"Liang","year":"2017","journal-title":"Biomaterials"},{"issue":"16","key":"10.1016\/j.biomaterials.2024.122573_bib48","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/marc.200500222","article-title":"Synthesis and characterization of novel aliphatic poly(carbonate-ester)s with functional pendent groups","volume":"26","author":"Zhou","year":"2005","journal-title":"Macromol. Rapid Commun."},{"issue":"9","key":"10.1016\/j.biomaterials.2024.122573_bib49","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/marc.200300319","article-title":"Novel biodegradable aliphatic polycarbonate based on ketal protected dihydroxyacetone","volume":"25","author":"Wang","year":"2004","journal-title":"Macromol. Rapid Commun."},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122573_bib50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.progpolymsci.2011.07.008","article-title":"Construction of functional aliphatic polycarbonates for biomedical applications","volume":"37","author":"Feng","year":"2012","journal-title":"Prog. Polym. Sci."},{"issue":"14","key":"10.1016\/j.biomaterials.2024.122573_bib51","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/j.compscitech.2005.04.051","article-title":"pH-compensation effect of bioactive inorganic fillers on the degradation of PLGA","volume":"65","author":"Li","year":"2005","journal-title":"Compos. Sci. Technol."},{"issue":"18","key":"10.1016\/j.biomaterials.2024.122573_bib52","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1039\/C8PY00406D","article-title":"Cholesterol functionalized aliphatic N-substituted 8-membered cyclic carbonate","volume":"9","author":"Venkataraman","year":"2018","journal-title":"Polym. Chem."},{"issue":"31","key":"10.1016\/j.biomaterials.2024.122573_bib53","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.1016\/j.biomaterials.2010.07.018","article-title":"Hydrogen bonding-enhanced micelle assemblies for drug delivery","volume":"31","author":"Kim","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2024.122573_bib54","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.biomaterials.2019.01.036","article-title":"Polymers with distinctive anticancer mechanism that kills MDR cancer cells and inhibits tumor metastasis","volume":"199","author":"Zhong","year":"2019","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.biomaterials.2024.122573_bib55","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1021\/jacs.7b11468","article-title":"Addressing drug resistance in cancer with macromolecular chemotherapeutic agents","volume":"140","author":"Park","year":"2018","journal-title":"J. Am. Chem. Soc."},{"issue":"23","key":"10.1016\/j.biomaterials.2024.122573_bib56","doi-asserted-by":"crossref","first-page":"19355","DOI":"10.1021\/acsami.8b01954","article-title":"Dual pH-responsive shell-cleavable polycarbonate micellar nanoparticles for in vivo anticancer drug delivery","volume":"10","author":"Liu","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"32","key":"10.1016\/j.biomaterials.2024.122573_bib57","doi-asserted-by":"crossref","first-page":"7971","DOI":"10.1016\/j.biomaterials.2013.07.005","article-title":"Hydrophobic modification of low molecular weight polyethylenimine for improved gene transfection","volume":"34","author":"Teo","year":"2013","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.biomaterials.2024.122573_bib58","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.biomaterials.2011.11.032","article-title":"The use of cholesterol-containing biodegradable block copolymers to exploit hydrophobic interactions for the delivery of anticancer drugs","volume":"33","author":"Lee","year":"2012","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.biomaterials.2024.122573_bib59","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nmat1737","article-title":"Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer","volume":"5","author":"Wang","year":"2006","journal-title":"Nat. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122573_bib60","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41568-021-00407-4","article-title":"The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs","volume":"22","author":"Diepstraten","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122573_bib61","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41467-022-29205-8","article-title":"CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity","volume":"13","author":"Joung","year":"2022","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biomaterials.2024.122573_bib62","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.cell.2022.03.030","article-title":"Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis","volume":"185","author":"Pan","year":"2022","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122573_bib63","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ccr3.3621","article-title":"The clinical course and management of cervical cancer with splenic metastasis: case report and review of the literature","volume":"9","author":"Liu","year":"2021","journal-title":"Clin. Case Rep."},{"issue":"8","key":"10.1016\/j.biomaterials.2024.122573_bib64","first-page":"4707","article-title":"Effect of interventional therapy on the expression of survivin mRNA in cervical cancer","volume":"37","author":"Wang","year":"2017","journal-title":"Anticancer Res."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961224001078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961224001078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T14:19:00Z","timestamp":1731766740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961224001078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":64,"alternative-id":["S0142961224001078"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122573","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymeric micellar nanoparticles for effective CRISPR\/Cas9 genome editing in cancer","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122573"}}